The silver tsunami and the elective arthroplasty crisis: How geriatric trauma overruns public surgical capacity

Abstract

Across Europe, orthopaedic departments face a growing disequilibrium: the sharply rising volume of geriatric trauma requiring urgent intervention versus the continued necessity for high‐value elective total joint arthroplasty to restore mobility, independence and quality‐adjusted life years. In most public systems, the escalation in proximal femoral fractures—driven by demographic shifts —absorbs operative capacity previously allocated to elective arthroplasty. Although trauma surgery should, by definition, be prioritised, the resulting displacement of elective total joint arthroplasty increasingly undermines the principles of value‐based care. This editorial discusses the drivers of this development, highlights the clinical and health‐economic consequences and outlines practical strategies that European health systems should consider to maintain timely trauma care without sacrificing access to elective arthroplasty.

Abbreviations

QALY

quality‐adjusted life years

TJA

total joint arthroplasty

INTRODUCTION

Orthopaedic and traumatology services in Europe have reached a critical crossroad. While the demographic shift towards an older population has been widely anticipated, its consequences on day‐to‐day surgical capacities are only now becoming fully visible. Specifically, the management of proximal femur fractures—where surgery within 24–48 h is an established quality criterion—has become the dominant factor shaping surgical scheduling in public hospitals [1, 35, 38, 44].

At the same time, thousands of patients await elective hip or knee arthroplasty. While their conditions are not acutely life‐threatening, the impact on their mobility, independence and socioeconomic participation is profound. Waiting lists of 6–12 months are no longer unusual [9, 22, 39]. The result is a growing structural conflict: acute trauma is prioritised, while elective arthroplasty is indefinitely postponed. Current literature reveals clear year‐on‐year increases in geriatric trauma cases that outpace non‐geriatric trauma and steadily compress the resources available for elective surgery [6, 23].

Demographic pressure and the rise of geriatric trauma

In many European trauma centers, elderly are accounting for increasing trauma presentations [3, 14, 26]. This represents a fundamental shift compared to two decades ago. The combination of frailty, multimorbidity and the severe medical consequences of delayed treatment renders geriatric trauma highly resource‐intensive [5, 28, 42]. Furthermore, there is a growing clinical and cultural shift towards earlier and more aggressive surgical management of fragility fractures (such as those of the sacrum and pelvic ring), which were traditionally treated conservatively. This change is driven by advances in implant technology and increasing evidence showing that surgical intervention reduces pain, shortens hospital stays, and enables faster and more effective patient mobilisation and autonomy [37, 40]. These cases occupy operating theatres, intermediate‐care beds and multidisciplinary teams ‐ often unpredictably and irrespective of previously planned elective lists. The epidemiological trend is unmistakable: geriatric trauma will continue to rise. Its impact on elective services is not a temporary anomaly but a structural reality [6, 23].

Elective arthroplasty: High‐value care in a disadvantaged position

Elective hip and knee arthroplasties are among the most successful and cost‐effective procedures in modern medicine [8, 43]. They restore autonomy and functional capacity, substantially improve quality‐adjusted life years (QALYs), reduce long‐term healthcare utilisation and frequently enable return to work in younger individuals [2, 34].

Nevertheless, elective arthroplasty lacks the immediate urgency that defines trauma care. In a resource‐limited environment, this perceived flexibility becomes a systemic disadvantage. When trauma volumes surge, elective total joint arthroplasty (TJA) patients are the first to be rescheduled — even though delays contribute to physical deterioration, increased pain, potential opioid dependency, secondary musculoskeletal damage, increased revision and postoperative complication rates [20]. This practice is inconsistent with value‐based healthcare, where high‐impact elective interventions should be protected rather than treated as a reservoir for overflow capacity [11, 13, 15, 45].

The financial symbiosis of elective and trauma care

The relationship between elective arthroplasty and emergency trauma services is often viewed purely through a clinical lens, yet the economic interdependence is equally critical. In many healthcare systems, high‐volume elective arthroplasty is profitable and effectively subsidises the high‐cost, unpredictable nature of geriatric trauma. Reduced elective capacity leads to lost patient care and destabilises the hospital's financial model, creating a “death spiral” of resources [12, 25].

Furthermore, this operational displacement severs the department's financial lifeline. Elective arthroplasty acts as a reliable revenue engine, generating the surplus needed to underwrite the unpredictable, resource‐heavy costs of geriatric trauma. By cancelling these elective lists to absorb emergency overflow, hospitals trade high‐margin efficiency for high‐cost chaos, effectively dismantling the very mechanism that keeps the trauma service financially viable [4, 8, 12, 17, 43].

Consequently, the loss of this ring‐fenced elective stream creates a deficit that pure trauma funding cannot fill. Without the regular injection of elective revenue, the department might lack the capital to invest in the staffing and infrastructure improvements required to handle the trauma burden efficiently. This creates a cycle of decline: the service becomes less efficient, costs rise further and pressure to reduce elective capacity increases, ultimately compromising care across both pathways.

Evidence from large‐scale trauma analyses

Recent studies provide empirical weight to these observations. The findings reveal that annual geriatric trauma volumes have increased significantly, with a slope far steeper than that of younger populations. Crucially, acute service demand is now consistently exceeding planned capacities [6, 23].

These data provide a quantitative explanation for the everyday clinical experience in European orthopaedics: elective arthroplasty is increasingly under pressure by trauma obligations [32].

The systemic consequences for the patient that are being postponed even further are severe, including:

• Progressive loss of mobility and function.

• Increased risk of long‐term disability and falls.

• Work incapacity and broader socioeconomic fallout.

• Psychological burden resulting from prolonged suffering.

• Inefficiencies caused by repeated preoperative assessments [21, 41].

For the health system, the impact includes:

• Higher long‐term costs due to delayed care.

• Increased need for rehabilitation and chronic pain management.

• Reduced surgical productivity due to frequent cancellations.

• Staff burnout caused by unpredictable trauma surges [16, 20, 31].

A frequently overlooked irony is that many geriatric trauma patients are individuals whose elective arthroplasty had been postponed — only to later present with a fracture resulting from declining mobility [18]. It has been shown that the prevalence of falls in geriatric populations awaiting surgery drops significantly after the procedure [7, 10]. Conversely, prolonged waiting times before joint replacement in patients with severe hip or knee osteoarthritis increase the risk of preoperative falls, which in turn is a predictor of postoperative fall risk [29]. In other words, keeping patients waiting too long for joint replacement surgery can potentially increase the incidence of traumatic events in the elderly population, both before and after the joint replacement surgery.

Reframing the debate

This challenge is not about choosing between trauma and arthroplasty as both are essential components of orthopaedic care. The core issue is that most public systems attempt to manage both streams within the same rigid operating room structure, without protected capacity lines. A modern surgical system must differentiate clearly between protected acute trauma capacity, protected elective arthroplasty capacity and flexible buffers to handle seasonal fluctuations.

Several European countries have already test run elective orthopaedic centers, regional trauma hubs, 'ring‐fenced' arthroplasty days that cannot be cancelled for trauma, activity‐based reimbursement models that protect high‐value procedures and predictive analytics for trauma seasonality. These models demonstrate that structural redesign is both feasible and effective [24, 30].

Crucially, structural separation alone is insufficient; the orthopaedic community must also address the root cause. It is becoming increasingly clear that we cannot simply operate our way out of the 'silver tsunami'. Surgeons must take active ownership of secondary prevention, particularly aggressive osteoporosis screening and management. Treating the fracture without treating the underlying bone fragility merely postpones the next admission, guaranteeing a recurring wave of trauma that further compounds the capacity crisis [19, 27, 33, 36].

CONCLUSION

The rise in geriatric trauma is not a temporary fluctuation but a long‐term demographic reality. If public systems continue to treat elective arthroplasty as a 'flexible add‐on' to acute trauma care, waiting lists will lengthen, outcomes will worsen and overall costs will rise. To maintain equitable and high‐value care, trauma services must remain fast and uncompromised. Simultaneously, elective arthroplasty requires protected operative capacity that is insulated from acute fluctuations. Without such reforms, the 'silver tsunami' will continue to overwhelm surgical capacity and patients will ultimately pay the price in lost mobility, independence and quality of life.

CONFLICT OF INTEREST STATEMENT

MT Hirschmann: Consulting fees from Depuy Synthes and Symbios; Honoraria for Lectures and Support attending Meetings from Depuy Synthes, Symbios, and S&N; Participation on Advisory Board for Depuy Synthes; Leadership positions in KSSTA Journal, ESSKA, German Knee Society, and Personalised Arthroplasty Society. P. Sadoghi: Industry grants from DePuy Synthes, Johnson & Johnson, alphamed, and Medacta; Editorial Board Member for JOA, KSSTA, and Arthroscopy. The remaining authors declare no conflicts of interest.

ETHICS STATEMENT

The authors have nothing to report.